Comparison

Narasin European Partner

Item no. TMO-T19740-25mg
Manufacturer TargetMol
Amount 25mg
Category
Type Molecules
Specific against other
Citations Nilsson O, Myrenås M, Ågren J. Transferable genes putatively conferring elevated minimum inhibitory concentrations of narasin in Enterococcus faecium from Swedish broilers. Vet Microbiol. 2016 Feb 29;184:80-3. doi: 10.1016/j.vetmic.2016.01.012. Epub 2016 Jan 18. PubMed PMID: 26854348.
Smiles O=C(O)C(CC)C1C(C)CC(C)C(C(C)C(O)C(C)C(C(C(C(C)CC2C)OC2(C=CC3O)OC43CCC(C)(C5CCC(O)(CC)C(C)O5)O4)CC)=O)O1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 55134-13-9
Available
Bioactivity
Narasin is a novel agent that inhibits dengue virus replication in vitro through non-cytotoxic mechanisms. It is used for the treatment of coccidiosis from a class of protozoa. It has been shown to foster the apoptosis of tumor cells.
MolWt
765.04

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25mg
Available: In stock
available

Delivery expected until 8/30/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?